ClinicaliQ Trial Snapshot
- Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) — Recruiting • Phase II • NCT07032662.
- A study testing whether a new drug called Imeroprubart helps adults with chronic nerve inflammation and weakness.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
This is a Phase 2b study to evaluate the efficacy and safety of Imeroprubart in adults with CIDP. Conditions: Chronic Inflammatory Demyelinating Polyneuropathy Interventions: Imeroprubart, Placebo Lead Sponsor: Immunovant Sciences GmbH Planned Enrollment: 162 participants